Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02162732 · ClinicalTrials.gov registry record · NA
Molecular-Guided Therapy for Childhood Cancer
A NA study, sponsored by Giselle Sholler.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
NCT02162732 is a NA study that has completed, run by Giselle Sholler. The registered enrollment target is 186 participants.
The verdict
NCT02162732, a NA study, has completed, sponsored by Giselle Sholler.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
Study Summary
The purpose of this study is to test the feasibility (ability to be done) of experimental technologies to determine a tumor's molecular makeup. This technology includes a genomic report based on DNA exomes and RNA sequencing that will be used to discover new ways to understand cancers and potentially predict the best treatments for patients with cancer in the future.
Interventions
- DEVICE Guided Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2014-07-08 |
| Est. Completion | 2024-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02162732
The ClinicalTrials.gov registry entry for NCT02162732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Giselle Sholler, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Guided Therapy is the first listed.
NCT02162732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02162732 about?
NCT02162732 is a clinical study titled "Molecular-Guided Therapy for Childhood Cancer". The purpose of this study is to test the feasibility (ability to be done) of experimental technologies to determine a tumor's molecular makeup. This technology includes a genomic report based on DNA exomes and RNA sequencing that will be used to discover new ways to understand cancers and potentiall...
What is the current status of trial NCT02162732?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2014-07-08. Estimated completion is 2024-01-18.
What interventions are being tested in trial NCT02162732?
The interventions under investigation include: Guided Therapy (DEVICE).
Who is sponsoring clinical trial NCT02162732?
This trial is sponsored by Giselle Sholler, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.